Brian Zhou
Associate Director, Genetic Medicine Search & Evaluation Eli Lilly
Brian Zhou is an accomplished Associate Director at Eli Lilly and Company, based in Boston, MA. He specializes in venture capital partnerships, direct investments, and business development in life sciences and health technologies. Brian has developed investment strategies for next-generation cell therapy, food allergy, vaccine, and other opportunities.
Brian holds a Ph.D. in Microbiology & Molecular Genetics and Environmental and Integrative Toxicological Science from Michigan State University. Fluent in English, Mandarin, and Cantonese, Brian has a proven track record in research, publication, and mentoring postdocs and biotech entrepreneurs.
Seminars
Saturday 29th August 2026
Search, Evaluation & Investment Panel: Understanding the Role of In Vivo Therapeutic in Shifting Investor & Pharma Strategies
4:00 pm
- Assessing how investors and pharma teams are integrating in vivo approaches into evolving pipeline and portfolio strategies
- Identifying the evidence and value inflection points shaping investment decisions for in vivo cell and gene therapy programs
- Aligning milestones, data packages and deal structures with shifting search, evaluation and investment priorities across the sector
